Clinical trials
Observational Disease Progression trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 8 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 2 |
| University Hospital Tuebingen | 2 |
| Ain Shams University | 1 |
| Carol Davila University of Medicine and Pharmacy | 1 |
| Casa Sollievo della Sofferenza IRCCS | 1 |
| Cedars-Sinai Medical Center | 1 |
| Charite University, Berlin, Germany | 1 |
| Chinese University of Hong Kong | 1 |
| Copenhagen University Hospital, Hvidovre | 1 |
| Corporacion Parc Tauli | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease Progression | 43 |
| Glaucoma | 3 |
| Multiple Sclerosis | 3 |
| Parkinson Disease | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Amyotrophic Lateral Sclerosis | 2 |
| Aortic Valve Stenosis | 2 |
| Osteosarcoma | 2 |
| Renal Insufficiency, Chronic | 2 |
| Ataxia Telangiectasia | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.